Le Lézard
Classified in: Health
Subjects: AWD, NPT, WOM, DEI

Friends of Prentice Awards More Than $350,000 to 2021 Grant Recipients


CHICAGO, June 24, 2021 /PRNewswire/ -- Friends of Prentice (FOP), a non-profit organization that works in partnership with Northwestern Medicine Prentice Women's Hospital to fund the future for women's healthcare, announced today they will be funding four critical research projects impacting the lives of women across the country. The exceptional physicians were selected as grant recipients of FOP's annual grant cycle based on their commitment to improving healthcare for all who self-identify as women in our immediate community and across the globe.

"We face a critical and vast knowledge gap in the areas of health, wellness and disease progression for women. We are committed to closing that gap through important research that will have a long-lasting and vital impact on women's health," said Kristen Field, Executive Director, Friends of Prentice. "These four projects were chosen for their demonstrated alignment and focus areas that ladder up to the mission of the organization ? to improve the health of women across the entire arc of their lives." 

The four projects chosen represent a variety of disciplines and groups of women they serve. 2021 recipients include:

Since 1983, Friends of Prentice has raised over $20M and awarded grants to more than 80 researchers and clinical programs. FOP's annual grants initiative has funded projects in the areas of gynecologic oncology, mental health, heart disease, disparities in access to care, diabetes, HIV, uterine and pelvic medicine, genetic biomarker research, home health care outreach and more. The research uncovered via the grant process is intended to improve women's healthcare across all socio-economic, racial and gender identity backgrounds.  Funds raised by FOP go directly to research, education, and patient care programs at Prentice.

"I am absolutely blown away by the generosity of Friends of Prentice, and I couldn't be more grateful. This grant gives me a renewed sense of optimism and confidence that I can continue building my research program, training graduate students, and advancing this exciting corner of science and medicine," said Dr. Kara Goldman, Medical Director, Fertility Preservation at Northwestern University Feinberg School of Medicine.

For more information on each of the grants, including full proposal abstracts, please reach out to the press contact below. For more information about Friends of Prentice or how to get involved or support the organization, please visit www.friendsofprentice.org

About Friends of Prentice
Friends of Prentice is committed to superior healthcare spanning the full spectrum of a woman's life at all ages and stages. The 501c3 nonprofit organization funds leading edge research initiatives at Northwestern Medicine Prentice Women's Hospital that improve the quality of health for all who self-identify as women in our immediate community and across the globe. The organization is comprised of a completely volunteer board, who all share a common passion for women's health. Friends of Prentice is committed to researching and improving women's healthcare across all socio-economic, racial and gender identity backgrounds including funding research in basic science, patient care, education and community service. To date, Friends of Prentice has raised over $20 million to support research, education and patient care programs at Prentice Women's Hospital.

Media Contacts:  
Megan Richards Martin
773-517-1826
[email protected]

Natalie Stanichuk
312-420-2225
[email protected]

SOURCE Friends of Prentice


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: